Non-small-cell Lung Cancer With Somatic EGFR Mutations

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB08916Afatinib2Terminated1
DB00642Pemetrexed2Terminated1